Status:
COMPLETED
Use of Technology to Optimize Hypertension Treatment in Elderly People in Primary Care
Lead Sponsor:
Federal University of Bahia
Conditions:
Systemic Arterial Hypertension
Pharmacotherapy
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The control of blood pressure (BP) in the elderly is influenced by several factors, among them, the measurement methodology. The measurement of BP in the office is prone to failures, so the use of tec...
Detailed Description
The study will be carried out at a municipal public pharmacy. The subjects will be users of the Family Pharmacy, aged 60 years or over, who seek the service to remove the drugs prescribed for the trea...
Eligibility Criteria
Inclusion
- Elderly with confirmation of a diagnosis of arterial hypertension (self-report, based on medical report or prescription)
- Using antihypertensive pharmacotherapy
Exclusion
- Users who, for whatever reason, are unable to perform MRPA.
Key Trial Info
Start Date :
June 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT04861727
Start Date
June 6 2021
End Date
August 30 2022
Last Update
October 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Farmácia Escola da UFBA, campus Anísio Teixeira
Vitória da Conquista, Estado de Bahia, Brazil, 45028440